We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Clinicopathological, immunophenotypic and genetic studies of mediastinal paragangliomas.
- Authors
Hsu, Ying-Han R; Torres-Mora, Jorge; Kipp, Benjamin R; Sukov, William R; Jenkins, Sarah M; Voss, Jesse S; Fritcher, Emily G Barr; Schaff, Hartzell V; Cassivi, Stephen D; Roden, Anja C
- Abstract
Open in new tab Download slide Open in new tab Download slide OBJECTIVES Paragangliomas have unique features in the mediastinum, in part due to their location. Because of their paucity, they have not been thoroughly investigated. We studied the clinical, pathological, immunohistochemical and molecular features of mediastinal paragangliomas. METHODS Immunohistochemistry, next-generation sequencing mutation panel and the Oncoscan assay were performed. RESULTS Twenty-four patients with mediastinal paraganglioma (7 men, 29.2%) had a median age of 45.5 years (19.8–72.2). Twenty-one (87.5%) paragangliomas were completely resected. Six (of 24, 25.0%) tumours were considered metastatic. Mitotic activity occurred in 11 (of 24, 45.8%) paragangliomas. Programmed death-ligand 1 (PD-L1) (n = 23) was expressed in 6 (26%) patients in 10% (n = 2) and 1% (n = 4) of tumour cells, respectively. SDHB expression was lost in 19 (of 22, 86.4%) cases. ATRX expression was lost in 11 (of 23, 47.8%) cases. Next-generation sequencing revealed a single pathogenic mutation in 10 (of 19) specimens including SDHB (n = 4), SDHD (n = 6), SDHC (n = 1), ATRX (n = 1), and ≥2 mutations in 2 cases [ SDHC and TERT (n = 1); SDHB , ATRX and TP53 (n = 1)]. Germline mutation analysis revealed the same succinate dehydrogenase mutation (or lack thereof) as identified in the paraganglioma in 11 (of 12) cases. During a median follow-up (n = 21) of 4.8 years (0.8–14.9), 3 patients developed metastases; 4 patients died, at least 1 of disease. CONCLUSIONS Mediastinal paragangliomas can be associated with morbidity and mortality. Many mediastinal paragangliomas have been reported to be associated with syndromes such as multiple endocrine neoplasia, von Hippel-Lindau or succinate dehydrogenase syndrome with mutation profiles dominated by alterations in genes associated with these syndromes.
- Subjects
PARAGANGLIOMA; SUCCINATE dehydrogenase; NUCLEOTIDE sequencing; MEDIASTINUM; CANCER; TERMINALLY ill
- Publication
European Journal of Cardio-Thoracic Surgery, 2019, Vol 56, Issue 5, p867
- ISSN
1010-7940
- Publication type
Article
- DOI
10.1093/ejcts/ezz115